Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Poletti

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|June 15, 2018
The containment of potential outbreaks triggered by imported Chikungunya cases in Italy: a cost utility epidemiological assessment of vector control measuresF Trentini, P Poletti, F Baldacchino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Axillary recurrence in sentinel lymph node-negative breast cancer patientsP Poletti, P Fenaroli, A Milesi, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2013
Response to chemotherapy of solitary fibrous tumour: a retrospective studyS Stacchiotti, M Libertini, T Negri, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2009
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected databaseM Mandalà, G L Imberti, D Piazzalunga, et al.
International Nursing Review|August 22, 2013
Nurses' preferred end-of-life treatment choices in five countriesA Coffey, G McCarthy, E Weathers, et al.
ESMO Open|August 9, 2024
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialF Poggio, E Blondeaux, M Tagliamento, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|June 15, 2018
The containment of potential outbreaks triggered by imported Chikungunya cases in Italy: a cost utility epidemiological assessment of vector control measuresF Trentini, P Poletti, F Baldacchino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Axillary recurrence in sentinel lymph node-negative breast cancer patientsP Poletti, P Fenaroli, A Milesi, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2013
Response to chemotherapy of solitary fibrous tumour: a retrospective studyS Stacchiotti, M Libertini, T Negri, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2009
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected databaseM Mandalà, G L Imberti, D Piazzalunga, et al.
International Nursing Review|August 22, 2013
Nurses' preferred end-of-life treatment choices in five countriesA Coffey, G McCarthy, E Weathers, et al.
ESMO Open|August 9, 2024
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialF Poggio, E Blondeaux, M Tagliamento, et al.
Pageof 3